The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model

[1]  M. Ando,et al.  Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G). , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Etienne Becht,et al.  Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy , 2016, Clinical Cancer Research.

[3]  L. Naldini,et al.  IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment , 2016, EMBO molecular medicine.

[4]  B. Melichar,et al.  Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry. , 2015, Anticancer research.

[5]  Jeong-Hwan Kim,et al.  Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels , 2015, Oncotarget.

[6]  A. Khorana,et al.  Integrating systemic and surgical approaches to treating metastatic colorectal cancer. , 2015, Surgical oncology clinics of North America.

[7]  Richard R. Smith,et al.  Liver-directed therapies in metastatic colorectal cancer. , 2014, Journal of gastrointestinal oncology.

[8]  T. Hielscher,et al.  Metastasis-Related Processes Show Various Degrees of Activation in Different Stages of Pancreatic Cancer Rat Liver Metastasis , 2014, Oncology Research and Treatment.

[9]  Jie Cao,et al.  Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression , 2014, OncoTargets and therapy.

[10]  R. Machii,et al.  Five-year relative survival rate of colon cancer in the USA, Europe and Japan. , 2014, Japanese journal of clinical oncology.

[11]  O. Bathe,et al.  Identification of prognostic inflammatory factors in colorectal liver metastases , 2014, BMC Cancer.

[12]  E. Ager,et al.  Bimodal role of Kupffer cells during colorectal cancer liver metastasis , 2013, Cancer biology & therapy.

[13]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[14]  Su-Hyung Hong,et al.  Phosphatase of regenerating liver‐3 promotes migration and invasion by upregulating matrix metalloproteinases‐7 in human colorectal cancer cells , 2012, International journal of cancer.

[15]  J. Kamps,et al.  Angiogenesis in Synchronous and Metachronous Colorectal Liver Metastases: The Liver as a Permissive Soil , 2012, Annals of surgery.

[16]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[17]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[18]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[19]  I. Fidler,et al.  AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.

[20]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[21]  J. Yun,et al.  Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer , 2009, International Journal of Colorectal Disease.

[22]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[23]  落合 大樹.  A new formula for predicting liver metastasis in patients with colorectal cancer : immunohistochemical analysis of a large series of 439 surgically resected cases , 2009 .

[24]  Alexander D. Diehl,et al.  Access to immunology through the Gene Ontology , 2008, Immunology.

[25]  S. Hirohashi,et al.  A New Formula for Predicting Liver Metastasis in Patients with Colorectal Cancer: Immunohistochemical Analysis of a Large Series of 439 Surgically Resected Cases , 2008, Oncology.

[26]  C. Nadal,et al.  Is there a genetic signature for liver metastasis in colorectal cancer? , 2007, World journal of gastroenterology.

[27]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[28]  G. Launoy,et al.  A population‐based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer , 2006, The British journal of surgery.

[29]  K. Hayashi,et al.  Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer , 2006, Clinical Cancer Research.

[30]  L. Matrisian,et al.  Matrix metalloproteinases in colorectal cancer: Is it worth talking about? , 2004, Cancer and Metastasis Reviews.

[31]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[32]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[33]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[34]  René Bernards,et al.  A progression puzzle. , 2002, Nature.

[35]  J. Guillem,et al.  Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  R Kath,et al.  Tumor progression and metastasis , 1990, Zentralblatt fur Chirurgie.

[37]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .